Pyrison Tablet

About Pyrison 25 mg Tablet

Pyrison 25 mg tablet contains pyrimethamine, an anti-malarial medicine. It is used to treat toxoplasmosis alongside a sulfonamide and for acute malaria, but not alone for malaria.

There are 2 brands of Pyrimethamine listed in Bangladesh. By unit price, Pyrison is among the cheapest of them.

What is Pyrison 25 mg Tablet?

Pyrison is a tablet form of pyrimethamine, belonging to a group of medicines called anti-malarials. It is prescribed for two main conditions: toxoplasmosis, where it is used together with a sulfonamide medicine, and acute malaria. For acute malaria, it is not used on its own; doctors combine it with faster-acting anti-malarial drugs. Pyrimethamine works by interfering with how the parasites make folate, a substance they need to survive. The doctor will decide the appropriate dose and length of treatment for each patient.

Uses of Pyrison

Pyrison is used to treat toxoplasmosis when given together with a sulfonamide, as the two medicines work better in combination. It is also used for acute malaria, but never alone; it must be combined with a faster-acting anti-malarial such as chloroquine. The doctor will determine whether this medicine is suitable for the specific infection.

How to use Pyrison

Pyrison tablets are taken by mouth. The exact dose, how often to take it, and how long to continue are decided by the doctor, who will adjust them based on the condition being treated and the patient's response. Do not change the dose or stop treatment without medical advice. Taking the tablet with meals may help reduce stomach upset. Follow the doctor's instructions carefully.

Side effects of Pyrison

Side effects can include allergic reactions, which may occasionally be severe, such as skin rashes or swelling. When used with a sulfonamide, other side effects related to that medicine may occur. At doses used for toxoplasmosis, loss of appetite and vomiting are possible; taking the medicine with meals may help, and vomiting usually stops if the dose is reduced. The doctor will monitor for other effects.

Safety and precautions

Pyrison should not be used by anyone with a known allergy to pyrimethamine or any ingredient, or with megaloblastic anemia due to folate deficiency. It is pregnancy category C, meaning it may harm an unborn baby; discuss pregnancy or breastfeeding with the doctor first. People with kidney or liver problems, folate deficiency, alcoholism, or those taking certain other medicines should tell the doctor before using it. The doctor will decide if it is safe for you.

Frequently asked questions

Who should avoid Pyrison or ask the doctor first?

Do not take Pyrison if you are allergic to pyrimethamine or have megaloblastic anemia from folate deficiency. Tell your doctor if you are pregnant or breastfeeding, have kidney or liver problems, or take other medicines, as these may affect safety.

What is Pyrison used for and what kind of medicine is it?

Pyrison is an anti-malarial medicine. It is used to treat toxoplasmosis together with a sulfonamide, and for acute malaria but only in combination with faster-acting anti-malarials. It is not used alone for malaria.

How should Pyrison be taken?

Pyrison is taken by mouth. The doctor decides the dose, how often, and how long you should take it, based on your condition. Do not change the dose yourself. Taking it with meals may reduce stomach upset. Follow your doctor's instructions carefully.

Can Pyrison be taken during pregnancy?

Pyrison is in pregnancy category C, meaning it may harm an unborn baby. If you are pregnant or planning pregnancy, talk to your doctor before taking this medicine. The doctor will weigh the benefits and risks for you.

Indications

Treatment of Toxoplasmosis: Pyrimethamine is indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination.

Treatment of Acute Malaria: Pyrimethamine is also indicated for the treatment ... Read moreTreatment of Toxoplasmosis: Pyrimethamine is indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination.

Treatment of Acute Malaria: Pyrimethamine is also indicated for the treatment of acute malaria. It should not be used alone to treat acute malaria. Fast-acting schizonticides such as chloroquine or quinine are indicated and preferable for the treatment of acute malaria. However, conjoint use of Pyrimethamine with a sulfonamide (e.g., sulfadoxine) will initiate transmission control and suppression of susceptible strains of plasmodia.

Chemoprophylaxis of Malaria: Pyrimethamine is indicated for the chemoprophylaxis of malaria due to susceptible strains of plasmodia. However, resistance to pyrimethamine is prevalent worldwide. It is not suitable as a prophylactic agent for travelers to most areas.

Pharmacology

Pyrimethamine is a folic acid antagonist structurally similar to trimethoprim. It inhibits parasitic dihydrofolate reductase, thus inhibiting vital tetrahydrofolic acid synthesis. It is active against pre-erythrocytic forms and is also a slow-acting schizontocide.

Dosage & Administration

For Treatment of Toxoplasmosis: The dosage of Pyrimethamine for the treatment of toxoplasmosis must be carefully adjusted so as to provide maximum therapeutic effect and a minimum of side effects. At the dosage required, there is a marked variation in the tolerance to the drug. Young patients may tolerate higher doses than older individuals. Concurrent administration of folinic acid is strongly recommended in all patients.

The adult starting dose is 50 to 75 mg of the drug daily, together with 1 to 4 g daily of a sulfonamide of the sulfapyrimidine type, e.g. sulfadoxine. This dosage is ordinarily continued for 1 to 3 weeks, depending on the response of the patient and tolerance to therapy. The dosage may then be reduced to about one half that previously given for each drug and continued for an additional 4 to 5 weeks.

The pediatric dosage of Pyrimethamine is 1 mg/kg/day divided into 2 equal daily doses; after 2 to 4 days this dose may be reduced to one half and continued for approximately 1 month. The usual pediatric sulfonamide dosage is used in conjunction with Pyrimethamine.

For Treatment of Acute Malaria: Pyrimethamine is NOT recommended alone in the treatment of acute malaria. Fast-acting schizonticides, such as chloroquine or quinine, are indicated for treatment of acute malaria. However, Pyrimethamine at a dosage of 25 mg daily for 2 days with a sulfonamide will initiate transmission control and suppression of non-falciparum malaria. Pyrimethamine is only recommended for patients infected in areas where susceptible plasmodia exist. Should circumstances arise wherein Pyrimethamine must be used alone in semi- immune persons, the adult dosage for acute malaria is 50 mg for 2 days; children 4 through 10 years old may be given 25 mg daily for 2 days. In any event, clinical cure should be followed by the once-weekly regimen described below for chemoprophylaxis. Regimens which include suppression should be extended through any characteristic periods of early recrudescence and late relapse, i.e., for at least 10 weeks in each case.

For Chemoprophylaxis of Malaria:
  • Adults and pediatric patients over 10 years: 25 mg (1 tablet) once weekly
  • Children 4 through 10 years: 12.5 mg (½ tablet) once weekly
  • Infants and children under 4 years: 6.25 mg (¼ tablet) once weekly.

Interaction

Pyrimethamine may be used with sulfonamides, quinine and other antimalarials, and with other antibiotics. However, the concomitant use of other antifolic drugs or agents associated with myelosuppression including sulfonamides or trimethoprim-sulfamethoxazole combinations, proguanil, zidovudine, or cytostatic agents (e.g., methotrexate), while the patient is receiving pyrimethamine, may increase the risk of bone marrow suppression. If signs of folate deficiency develop, pyrimethamine should be discontinued. Folinic acid (leucovorin) should be administered until normal hematopoiesis is restored

Contraindications

Use of Pyrimethamine is contraindicated in patients with known hypersensitivity to pyrimethamine or to any component of the formulation. Use of the drug is also contraindicated in patients with documented megaloblastic anemia due to folate deficiency.

Side Effects

Hypersensitivity reactions, occasionally severe (such as Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, and anaphylaxis), and hyperphenylalaninemia, can occur particularly when pyrimethamine is administered concomitantly with a sulfonamide. Consult the complete prescribing information for the relevant sulfonamide for sulfonamideassociated adverse events. With doses of pyrimethamine used for the treatment of toxoplasmosis, anorexia and vomiting may occur. Vomiting may be minimized by giving the medication with meals; it usually disappears promptly upon reduction of dosage. Doses used in toxoplasmosis may produce megaloblastic anemia, leukopenia, thrombocytopenia, pancytopenia, neutropenia, atrophic glossitis, hematuria, and disorders of cardiac rhythm.

Pregnancy & Lactation

Pregnancy Category C. Pyrimethamine has been shown to be teratogenic in rats when given in oral doses 7 times the human dose for chemoprophylaxis of malaria or 2.5 times the human dose for treatment of toxoplasmosis. At these doses in rats, there was a significant increase in abnormalities such as cleft palate, brachygnathia, oligodactyly, and microphthalmia. Pyrimethamine has also been shown to produce terata such as meningocele in hamsters and cleft palate in miniature pigs when given in oral doses 170 and 5 times the human dose, respectively, for chemoprophylaxis of malaria or for treatment of toxoplasmosis.

There are no adequate and well-controlled studies in pregnant women. Pyrimethamine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Concurrent administration of folinic acid is strongly recommended when used for the treatment of toxoplasmosis during pregnancy.

Nursing Mothers: Pyrimethamine is excreted in human milk. Because of the potential for serious adverse reactions in nursing infants from pyrimethamine and from concurrent use of a sulfonamide with Pyrimethamine for treatment of some patients with toxoplasmosis, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother

Precautions & Warnings

The recommended dosage for chemoprophylaxis of malaria should not be exceeded. Pyrimethamine should be used with caution in patients with impaired renal or hepatic function or in patients with possible folate deficiency, such as individuals with malabsorption syndrome, alcoholism, or pregnancy, and those receiving therapy, such as phenytoin, affecting folate levels

Alternative brands of Pyrimethamine

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.